CREDIT SUISSE AG/ – Abiomed, Inc. Transaction History
CREDIT SUISSE AG/ portfolio value:
$86.95M
portfolio value
CREDIT SUISSE AG/ quarter portfolio value change:
-0.75%
quarter
Abiomed, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.94% | -22.33K shares | -6.18M | $245.66 | 353.95K |
| Q2 2022 | share | Decrease | -10.81% | -45.59K shares | -46.61M | $247.51 | 376.29K |
| Q1 2022 | share | Decrease | -33.34% | -211.03K shares | -87.58M | $331.24 | 421.89K |
| Q4 2021 | share | Decrease | -14.64% | -108.52K shares | -14.02M | $362.06 | 632.92K |
| Q3 2021 | share | Decrease | -13.06% | -111.34K shares | -24.80M | $325.52 | 741.44K |
| Q3 2021 | call | Decrease | -100.00% | -23.8K shares | -7.42M | $325.52 | 0 |
| Q2 2021 | call | Increase | 0.00% | 23.8K shares | 7.42M | $312.11 | 23.8K |
| Q2 2021 | share | Decrease | -5.87% | -53.20K shares | -22.60M | $312.11 | 852.78K |
| Q1 2021 | share | Increase | +31.38% | 216.40K shares | 65.20M | $318.73 | 905.99K |
| Q4 2020 | call | Decrease | -100.00% | -19.4K shares | -5.37M | $324.2 | 0 |
| Q4 2020 | share | Increase | +6.98% | 44.97K shares | 44.97M | $324.2 | 689.58K |
| Q3 2020 | share | Decrease | -10.87% | -78.62K shares | 3.89M | $277.06 | 644.60K |
| Q3 2020 | call | Increase | 0.00% | 19.4K shares | 5.37M | $277.06 | 19.4K |
| Q2 2020 | share | Decrease | -3.96% | -29.83K shares | 65.38M | $241.56 | 723.22K |
| Q1 2020 | share | Increase | +22.86% | 140.09K shares | 4.74M | $145.16 | 753.06K |
| Q4 2019 | share | Increase | +135.40% | 352.57K shares | 58.24M | $170.59 | 612.96K |
| Q3 2019 | put | Decrease | -100.00% | -3.2K shares | -834K | $177.89 | 0 |
| Q3 2019 | share | Increase | +27.60% | 56.32K shares | -6.83M | $177.89 | 260.38K |
| Q2 2019 | share | Increase | +7.38% | 14.01K shares | -1.11M | $260.49 | 204.06K |
| Q2 2019 | put | Increase | 0.00% | 3.2K shares | 834K | $260.49 | 3.2K |
| Q1 2019 | share | Increase | +7.90% | 13.91K shares | -2.97M | $285.59 | 190.04K |
| Q4 2018 | share | Increase | +32.70% | 43.40K shares | -2.44M | $325.04 | 176.12K |
| Q3 2018 | share | Increase | +28.58% | 29.50K shares | 17.47M | $449.75 | 132.72K |
| Q2 2018 | share | Increase | +105.09% | 52.89K shares | 27.57M | $409.05 | 103.22K |
| Q1 2018 | share | Decrease | -8.08% | -4.42K shares | 4.38M | $290.99 | 50.33K |
| Q4 2017 | share | Increase | +21.92% | 9.84K shares | 2.69M | $187.41 | 54.75K |
| Q3 2017 | share | Decrease | -30.53% | -19.73K shares | -1.69M | $168.6 | 44.90K |
| Q2 2017 | share | Decrease | -6.95% | -4.82K shares | 566K | $143.3 | 64.64K |
| Q1 2017 | share | Decrease | -6.38% | -4.73K shares | 338K | $125.2 | 69.46K |
| Q4 2016 | share | Decrease | -9.92% | -8.17K shares | -2.23M | $112.68 | 74.19K |
| Q3 2016 | share | Decrease | -36.14% | -46.62K shares | -3.50M | $128.58 | 82.37K |
| Q2 2016 | share | Increase | +90.67% | 61.33K shares | 7.68M | $109.29 | 128.99K |
| Q1 2016 | share | Increase | +28.32% | 14.93K shares | 1.65M | $94.81 | 67.65K |